Statistics for Medincell SA (id:10806 MEDCL)

Valuation metrics

Market cap

525.96M

Enterprise value

571.15M

Trailing P/E (ttm)

-20.57

Forward P/E

90.40

PEG ratio

90.40

Price/Sales (ttm)

44.03

Price/Book (mrq)

Enterprise Value/Revenue

47.82

Enterprise Value/EBITDA

-28.49

Overview

Shares outstanding

29.09M

Float

20.90M

Shares short

% Held by insiders

0.39%

% Held by institutions

0.25%

Average volume (10 days)

68.32K

Average volume (90 days)

Price summary

52-Week low

5.92

52-Week high

19.00

52-Week change

66.19%

Beta

1.20

50-Day moving average

16.06

200-Day moving average

14.19

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

March 31th, 2024

Most recent quarter (mrq)

March 31th, 2024

Profitability

Profit margin

-209.61%

Operating margin

-318.27%

Operational effectiveness

Return on assets

-39.49%

Return on equity

61.33%

Income statement

Revenue (ttm)

0.42

Revenue per share (ttm)

0.42

Quarterly revenue growth (yoy)

Gross profit (ttm)

9.16M

EBITDA

-20,046,000.00

Net income to common (ttm)

-25,038,000.00

Diluted EPS (ttm)

-0.88

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

19.46M

Total cash per share (mrq)

0.67

Total debt (mrq)

64.71M

Total Debt/Equity (mrq)

-1.58

Current ratio (mrq)

165.50%

Book value per share (mrq)

-1.40

Cash flow

Cash flow statement

-11,922,000.00

Levered free cash flow (LFCF)

-10,601,125.00